The Patients Before Monopolies Act aims to enhance competition in the pharmacy market and reduce drug prices for patients by prohibiting the ownership of both pharmacy benefit managers (PBMs) and pharmacies by the same entity. This legislation seeks to eliminate conflicts of interest that can arise when a single company controls both aspects of the healthcare supply chain. The Act establishes a clear prohibition against any entity owning both a pharmacy and a PBM or insurance company.